Navigation Links
Ableware® Patient Slide Mobility Device Makes Repositioning Easier
Date:5/10/2013

Wayne, NJ (PRWEB) May 10, 2013

Caring for an individual who has trouble staying in an upright seated position can be difficult and, in some cases, can cause back strain for the caregiver and injuries to the person needing assistance. Maddak’s new Patient Slide Mobility Device is designed to provide caregivers with an easier, safer way to reseat an individual to the back of a chair for better support.

Kathleen Hanek, Director of Product Development for Maddak Inc., manufacturer of Ableware® aids for daily living says, “Often, people with difficulty sitting upright will find themselves in the dangerous position of being seated at the front edge of a chair. A caregiver’s first response will be to grab the person and pull them to the back of the seat. Repeated grabbing and pulling of the individual to get them into a proper sitting position can lead to a caregiver unintentionally bruising or irritating the patient’s skin, or possibly causing an injury. The Patient Slide provides a method of repositioning an individual to an upright seated position at the back of a chair in a manner that is easier, more efficient and safer for both the caregiver and the person requiring assistance.”

The Patient Slide is 46” (116.8 cm) long with three sets of handles to accommodate various sized individuals and seating scenarios. The smooth surface on one side reduces friction allowing it to easily move across the chair, while the non-slip material on the other side holds the patient safely in place during the repositioning process.

Hanek further explained, “To use the Patient Slide the caregiver slides the device under the patient’s legs so that one set of handles is on each side. Then standing behind the patient,
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Higher-spending hospitals have fewer deaths for emergency patients
2. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
3. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
4. Study finds doctors have exaggerated fears when starting patients on insulin
5. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
6. Predictors identified for rehospitalization among post-acute stroke patients
7. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Heart failure patients with diabetes may benefit from higher glucose levels
10. Gastro Woes Often Strike Rheumatoid Arthritis Patients
11. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day ... in the nation! This year, on May 5th, 2015, Secura ... take DI Day on the road by supporting the first ... RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants and ... change by stating, "The first Twin Cities DI Day was ...
(Date:4/24/2015)... As the nation recognizes the Month of the ... young men and women, the “Alaska – Forget Me ... presents a special training session on Adverse Childhood Experiences ... understanding of the effect of childhood trauma and, in ... and military – who provide services and support to ...
(Date:4/24/2015)... 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... federal multidistrict litigation underway in U.S. District Court, ... the parties involved in the proceeding submitted a ... other things, preparation for the litigation’s upcoming bellwether ... plaintiffs and defendants have conducted depositions of non-party ...
(Date:4/24/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... auto insurance for senior citizens . , Senior ... does not mean that they cannot find affordable coverage. ... can find the right coverage for their cars at ... like http://lowcostcarinsuranceprice.com/ provides free leads from various ...
(Date:4/24/2015)... Olive Fertility Centre is proud to ... co-director, has been honoured for his pioneering work in ... Hope Gala. , “We are very pleased to ... has been at the forefront of fertility research and ... Executive Director of Fertile Futures--a Canadian non-profit organization that ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2
... This release is available in Spanish . ... acuity, between now and the year 2020, more and more ... age-related macular degeneration (AMD) and other sight-robbing diseases. ... Nutrition and Vision Research are finding that healthy eating can ...
... because of the potential to provide more durable and widespread ... cells. Now, researchers at Children,s Hospital Boston and their colleagues ... most common form of human lung cancer and, more significantly, ... tumor to tumor, depending upon the tumor,s genetic signature. ...
... , THURSDAY, July 1 (HealthDay News) -- ... uterine fibroids and helps women with the non-cancerous tumors ... pain and heavy menstrual bleeding, are a leading cause ... "Both the fibroids and the surgical interventions commonly used ...
... ... campaign is the first of its kind for designer and includes the ... cities across the country, national advertising, a bus wrap in Chicago, and ... colors and styles on July 8th, Vera Bradley is encouraging people across ...
... The Parkinson,s Disease Foundation (PDF) is pleased to announce ... understand the cause(s) of and find a cure for ... the work of 15 leading scientists and are provided ... and Research Fellowship Grants. The first program seeks ...
... ... Together to Share Ideas and Innovate , ... Braintree, MA (PRWEB) July 1, 2010 -- WorldAPP, a global on-demand web-application company, ... can come together to share ideas about all aspects of the data collection process. , ...
Cached Medicine News:Health News:Cancer stem cells are not 1 size fits all, lung cancer models show 2Health News:Drug May Shrink Fibroids, Preserve Fertility 2Health News:Vera Bradley Launches National “Be Colorful” Campaign 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 3Health News:WorldAPP Launches User Community 2Health News:WorldAPP Launches User Community 3
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... of the "Global Biobanking Market 2015-2019" report ... Global Biobanking market to grow at a CAGR of ... Biobanking market can be divided into two segments: Equipment ... the growth prospects of the Global Biobanking market for ...
(Date:4/24/2015)... 24, 2015 The National Institute of ... National Institutes of Health [NIH])  provided grants totaling ... for the development of diagnostic tests for antibiotic-resistant ... at U.S. health facilities , the NIAID and ... multiplexed and effective tests using alternative methods to ...
(Date:4/24/2015)... Hospira, Inc. (NYSE: HSP ... therapies, spoke about the importance of extrapolation in bringing ... (EGA) annual European Biosimilars Group conference in ... the publication of a pivotal white paper titled, ... of biosimilars." Speaking at the EGA ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7
... - Additional data reinforce long-term efficacy of ACTEMRA ... - , , , NUTLEY, N.J., June ... LITHE (Toci LI zumab Safety and THE ... greater proportion of rheumatoid arthritis (RA) patients treated with ...
... Issue of Circulation , , SILVER SPRING, Md. ... UTHR ) and Eli Lilly and Company ... of a pivotal 16-week study showing that a once-daily ... capacity and improved time to clinical worsening in patients ...
Cached Medicine Technology:Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 2Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 3Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 5Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 6Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 7Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 8Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 2Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 3Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 4Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 5Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 6
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... one-piece baseplate is designed specifically ... thicker than the current Assura, ... erosion for longer. The product ... piece and two piece, both ...
... kit for the screening of factor-V-related APC ... the test for the factor V:Q506 mutation ... with an excess of V-DEF Plasma bioreagent. ... discriminate between heterozygous and homozygous factor V ...
Medicine Products: